Drug Type Gene editing |
Synonyms ABO 102 (Arbor Biotechnologies), ABO102 (Arbor Biotechnologies) |
Target |
Action inhibitors |
Mechanism TTR inhibitors(Transthyretin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyloidosis, Hereditary, Transthyretin-Related | Discovery | United States | 06 Jul 2023 |